The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist. Issue 1 (February 2018) - Di Matteo, S.; Nevi, L.; Costantini, D.; Colantonio, M.; Giulitti, F.; Napoletano, C.; Safarikia, S.; Manzi, E.; Derose, A.M.; Melandro, F.; Bragazzi, M.C.; Grazi, G.; et al.